Shiri-Sverdlov R - Search Results

1

Inflammatory Bowel Disease: A Stressed "Gut/Feeling".

Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Oligschlaeger Y, et al. Cells. 2019 Jun 30;8(7):659. doi: 10.3390/cells8070659. Cells. 2019. PMID: 31262067 Free PMC article. Review.

2

Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice.

Hendrikx T, Jeurissen ML, Bieghs V, Walenbergh SM, van Gorp PJ, Verheyen F, Houben T, Guichot YD, Gijbels MJ, Leitersdorf E, Hofker MH, Lütjohann D, Shiri-Sverdlov R. Hendrikx T, et al. J Hepatol. 2015 Feb;62(2):430-6. doi: 10.1016/j.jhep.2014.09.027. Epub 2014 Oct 2. J Hepatol. 2015. PMID: 25281859

3

The immunity-diet-microbiota axis in the development of metabolic syndrome.

Brandsma E, Houben T, Fu J, Shiri-Sverdlov R, Hofker MH. Brandsma E, et al. Curr Opin Lipidol. 2015 Apr;26(2):73-81. doi: 10.1097/MOL.0000000000000154. Curr Opin Lipidol. 2015. PMID: 25692344 Review.

4

Plasma cathepsin D levels: a novel tool to predict pediatric hepatic inflammation.

Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vreugdenhil AC, Adriaanse MP, Buurman WA, Hofker MH, Mosca A, Lindsey PJ, Alisi A, Liccardo D, Panera N, Koek GH, Nobili V, Shiri-Sverdlov R. Walenbergh SM, et al. Am J Gastroenterol. 2015 Mar;110(3):462-70. doi: 10.1038/ajg.2015.29. Epub 2015 Mar 3. Am J Gastroenterol. 2015. PMID: 25732418

5

Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.

Hendrikx T, Jeurissen ML, van Gorp PJ, Gijbels MJ, Walenbergh SM, Houben T, van Gorp R, Pöttgens CC, Stienstra R, Netea MG, Hofker MH, Donners MM, Shiri-Sverdlov R. Hendrikx T, et al. FEBS J. 2015 Jun;282(12):2327-38. doi: 10.1111/febs.13279. Epub 2015 Apr 20. FEBS J. 2015. PMID: 25817537 Free article.

6

Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice.

Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vaes N, Olde Damink SW, Verheyen F, Koek GH, Lütjohann D, Grebe A, Latz E, Shiri-Sverdlov R. Walenbergh SM, et al. Int J Mol Sci. 2015 Sep 2;16(9):21056-69. doi: 10.3390/ijms160921056. Int J Mol Sci. 2015. PMID: 26404254 Free PMC article.

7

Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis.

Hendrikx T, Walenbergh SM, Jeurissen ML, Houben T, van Gorp PJ, Lindsey PJ, Koek GH, Kalhan S, Pihlajamaki J, Hofker MH, Shiri-Sverdlov R. Hendrikx T, et al. Biomark Med. 2015;9(12):1301-9. doi: 10.2217/bmm.15.71. Epub 2015 Nov 19. Biomark Med. 2015. PMID: 26612588

8

Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis.

Houben T, Brandsma E, Walenbergh SMA, Hofker MH, Shiri-Sverdlov R. Houben T, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Apr;1862(4):416-429. doi: 10.1016/j.bbalip.2016.07.008. Epub 2016 Jul 27. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. PMID: 27472963 Review.

9

MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis.

Chanda D, Li J, Oligschlaeger Y, Jeurissen ML, Houben T, Walenbergh SM, Shiri-Sverdlov R, Neumann D. Chanda D, et al. Exp Mol Med. 2016 Sep 9;48(9):e258. doi: 10.1038/emm.2016.79. Exp Mol Med. 2016. PMID: 27609031 Free PMC article.

10

Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model.

Li J, Chanda D, van Gorp PJ, Jeurissen ML, Houben T, Walenbergh SM, Debets J, Oligschlaeger Y, Gijbels MJ, Neumann D, Shiri-Sverdlov R. Li J, et al. PLoS One. 2016 Sep 29;11(9):e0163843. doi: 10.1371/journal.pone.0163843. eCollection 2016. PLoS One. 2016. PMID: 27685150 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page